SCHEMBL13537262

SCHEMBL13537262

CCNC(=O)/C(N)=C1\SCC(=O)N1CC

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ALDH1A1 P00352 8/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ ATM Q13315 1/20 0.36
▸ HTT P42858 3/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ USP2 O75604 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ GSK3A P49840 1/20 0.33
▸ GSK3B P49841 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13537363 0.90 MEN1 (0.38) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537632 0.86 ALDH1A1 (0.37) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537259 0.85 MEN1 (0.38) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537263 0.85 MAPT (0.36) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537426 0.83 MEN1 (0.34) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537540 0.83 KMT2A (0.43) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537424 0.80 MEN1 (0.36) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13488664 0.79 ALDH1A1 (0.49) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL3358918 0.79 ALDH1A1 (0.49) MEN1KMT2AMAPTHSD17B10ALDH1A1
SCHEMBL13537354 0.78 MAPT (0.34) MEN1KMT2AMAPTHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 — — EP disclosed
Send feedback